Advertisement

Drugs & Therapy Perspectives

, Volume 34, Issue 6, pp 259–262 | Cite as

Be prudent when prescribing medications to the elderly to minimize the risk of drug-induced kidney injury

  • Adis Medical Writers
Drug Reactions and Interactions
  • 63 Downloads

Abstract

Of the increasing number of acute kidney injuries in the elderly, many are drug induced. The elderly are particularly susceptible to acute kidney injury due to age-related renal changes and increased drug use. Although treatments for drug-induced kidney injury are currently lacking, prudent drug selection and monitoring for changes in renal function can prevent its occurence.

Notes

Compliance with ethical standards

Conflict of interest

The article was adapted from Drugs Aging 2017;34(10):729–41 [4] by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.

Funding

The preparation of this review was not supported by any external funding.

References

  1. 1.
    Yilmaz R, Erdem Y. Acute kidney injury in the elderly population. Int Urol Nephrol. 2010;42(1):259–71.CrossRefPubMedGoogle Scholar
  2. 2.
    USRDS annual data report. https://www.usrds.org/2016/view/Default.aspx. Accessed 05 Feb 2018.
  3. 3.
    Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007;18(4):1292–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Khan S, Loi V, Rosner MH. Drug-induced kidney injury in the elderly. Drugs Aging. 2017;34(10):729–41.CrossRefPubMedGoogle Scholar
  5. 5.
    Denic A, Lieske JC, Chakkera HA, et al. The substantial loss of nephrons in healthy human kidneys with aging. J Am Soc Nephrol. 2017;28(1):313–20.CrossRefPubMedGoogle Scholar
  6. 6.
    Schmitt R, Coca S, Kanbay M, et al. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis. 2008;52(2):262–71.CrossRefPubMedGoogle Scholar
  7. 7.
    Barros EJ, Boim MA, Ajzen H, et al. Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. Kidney Int. 1987;32(1):19–25.CrossRefPubMedGoogle Scholar
  8. 8.
    First MR, Schroeder TJ, Alexander JW, et al. Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients. Transplantation. 1991;51(2):365–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Morrissey KM, Stocker SL, Wittwer MB, et al. Renal transporters in drug development. Annu Rev Pharmacol Toxicol. 2013;53:503–29.CrossRefPubMedGoogle Scholar
  10. 10.
    Perazella MA. Drug-induced nephropathy: an update. Expert Opin Drug Saf. 2005;4(4):689–706.CrossRefPubMedGoogle Scholar
  11. 11.
    Markowitz GS, Bomback AS, Perazella MA. Drug-induced glomerular disease: direct cellular injury. Clin J Am Soc Nephrol. 2015;10(7):1291–9.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Izzedine H, Escudier B, Lhomme C, et al. Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center. Medicine (Baltim). 2014;93(24):333–9.CrossRefGoogle Scholar
  13. 13.
    Michel DM, Kelly CJ. Acute interstitial nephritis. J Am Soc Nephrol. 1998;9(3):506–15.PubMedGoogle Scholar
  14. 14.
    Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta. 2005;351(1–2):31–47.CrossRefPubMedGoogle Scholar
  15. 15.
    Luque Y, Louis K, Jouanneau C, et al. Vancomycin-associated cast nephropathy. J Am Soc Nephrol. 2017;28(6):1723–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Zeller V, Puyraimond-Zemmour D, Sene T, et al. Amoxicillin crystalluria, an emerging complication with an old and well-known antibiotic. Antimicrob Agents Chemother. 2016;60(5):3248.  https://doi.org/10.1128/AAC.00359-16.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Kohli HS, Bhaskaran MC, Muthukumar T, et al. Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant. 2000;15(2):212–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Jerkic M, Vojvodic S, Lopez-Novoa JM. The mechanism of increased renal susceptibility to toxic substances in the elderly. Part I: the role of increased vasoconstriction. Int Urol Nephrol. 2001;32(4):539–47.CrossRefPubMedGoogle Scholar
  19. 19.
    Chang YP, Huang SK, Tao P, et al. A population-based study on the association between acute renal failure (ARF) and the duration of polypharmacy. BMC Nephrol. 2012;13:96.  https://doi.org/10.1186/471-2369-13-96.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother. 2011;9(6):364–77.CrossRefPubMedGoogle Scholar
  21. 21.
    Nair R, Bell JM, Walker PD. Renal biopsy in patients aged 80 years and older. Am J Kidney Dis. 2004;44(4):618–26.CrossRefPubMedGoogle Scholar
  22. 22.
    Gujjarlamudi HB. Polytherapy and drug interactions in elderly. J Midlife Health. 2016;7(3):105–7.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations